X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
0.370
-0.001 (-0.32%)
At close: Dec 3, 2024, 4:00 PM
0.363
-0.007 (-1.81%)
After-hours: Dec 3, 2024, 7:43 PM EST
X4 Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -16.76 | -101.17 | -93.87 | -88.7 | -62.13 | -52.81 | |
| Depreciation & Amortization | 0.59 | 0.42 | 0.51 | 0.5 | 0.35 | 0.1 | |
| Other Amortization | 0.9 | 0.93 | 0.92 | 0.76 | 0.53 | 0.7 | |
| Loss (Gain) From Sale of Assets | -105 | - | - | - | - | 3.9 | |
| Asset Writedown & Restructuring Costs | - | - | - | 9.76 | - | - | |
| Stock-Based Compensation | 8.53 | 8.69 | 5.2 | 6.18 | 5.43 | 2.05 | |
| Other Operating Activities | -10.03 | -5.72 | 4.4 | 2.1 | 1.07 | 1.24 | |
| Change in Accounts Payable | 0.44 | 1.23 | 3.43 | 1.17 | 1.03 | -2.75 | |
| Change in Other Net Operating Assets | -1.88 | -0.89 | 2.31 | -2.66 | -5.09 | -0.48 | |
| Operating Cash Flow | -125.65 | -96.51 | -77.1 | -70.91 | -58.82 | -48.06 | |
| Capital Expenditures | -0.32 | -0.06 | -0.1 | -0.62 | -1.36 | -0.17 | |
| Cash Acquisitions | - | - | - | - | - | 26.41 | |
| Investment in Securities | -26.9 | -14.82 | - | - | - | - | |
| Other Investing Activities | - | - | - | - | - | 1 | |
| Investing Cash Flow | 70.78 | -14.88 | -0.1 | -0.62 | -1.36 | 27.23 | |
| Long-Term Debt Issued | - | 22.5 | - | - | 12.39 | 9.85 | |
| Long-Term Debt Repaid | - | -2.06 | -0.8 | - | - | -9.37 | |
| Net Debt Issued (Repaid) | 20 | 20.44 | -0.8 | - | 12.39 | 0.48 | |
| Issuance of Common Stock | 0.26 | 68.71 | 122.84 | 76.25 | 0.56 | 140.18 | |
| Repurchase of Common Stock | - | - | -0.01 | -2 | -0.28 | - | |
| Other Financing Activities | - | -0.63 | -4.8 | - | -0.28 | - | |
| Financing Cash Flow | 20.26 | 88.52 | 117.23 | 74.25 | 12.39 | 140.66 | |
| Foreign Exchange Rate Adjustments | 0.22 | 0.1 | -0.11 | -0.32 | 0.4 | -0.25 | |
| Net Cash Flow | -34.4 | -22.78 | 39.92 | 2.41 | -47.38 | 119.59 | |
| Free Cash Flow | -125.97 | -96.57 | -77.21 | -71.52 | -60.18 | -48.23 | |
| Free Cash Flow Margin | -11217.54% | - | - | - | -2006.00% | - | |
| Free Cash Flow Per Share | -0.63 | -0.54 | -1.22 | -2.78 | -3.00 | -4.18 | |
| Cash Interest Paid | 4.6 | 4.6 | 3.01 | 2.91 | 2.1 | 1.28 | |
| Levered Free Cash Flow | -82.41 | -59.79 | -44.23 | -43.05 | -33.04 | -28.1 | |
| Unlevered Free Cash Flow | -78.1 | -57.1 | -42.65 | -41.53 | -31.9 | -27.46 | |
| Change in Net Working Capital | -1.91 | -1.05 | -6.79 | 0.5 | -1.11 | -0.44 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.